← Back to Patent Explorer
US3983227A Expired / Lapsed US ⏱️ 0.0 years remaining

Dry mixture containing diphosphonates and a stannous salt useful in the preparation of Tc99M containing bone scanning agents

Assignee: Mallinckrodt Inc
•
Filing: 1974-04-19
•
Granted: 1976-09-28
•
Expires: 1994-04-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A composition and method for the preparation of a technetium-99m based scintigraphic scanning agent are disclosed. The agent is prepared by the addition of a pertechnetate-99m solution to an anhydrous salt composition comprising a phosphonic acid or a pharmaceutically acceptable salt thereof and a non-toxic, water-soluble, anhydrous, stannous, ferrous or chromous salt of hydrochloric or sulfuric acid.

Inventors

  • 👤 Andrew John Tofe
  • 👤 Marion David Francis

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 15:32
CPC Classifications
A; A61; A61K; A61K51/00; A61K51/12; A61K51/1282; A61K51/02; A61K51/04; A61K51/0489; A61K2123/00; Y; Y10; Y10T; Y10T436/00; Y10T436/10; Y10T436/108331

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 113 words
A composition for the preparation of an improved bone scanning agent comprising a dry mixture of: A. a phoshonate which is a member selected from the group consisting of (i) disodium-ethane-1-hydroxy-1,1-diphosphonate, (ii) a mixture of disodium- and trisodium-ethane-1-hydroxy-1,1-diphosphonate salts, the mole ratio of the disodium to trisodium salt being from about 4:1 to 1:1, (iii) dichloromethane diphosphonic acid, or the pharmaceutically acceptable salts thereof, and (iv) methane diphosphonic acid, or the pharmaceutically acceptable salts thereof; B. an amount of an anhydrous reducing metal salt which is a member selected from the group consisting of stannous chloride and stannous sulfate sufficient to provide a molar ratio of stannous:phosphonate of from about 1:15 to 1:80.
Claim 2
Dependent Claim 113 words
A composition for the preparation of an improved bone scanning agent comprising a dry mixture of: A. a phoshonate which is a member selected from the group consisting of (i) disodium-ethane-1-hydroxy-1,1-diphosphonate, (ii) a mixture of disodium- and trisodium-ethane-1-hydroxy-1,1-diphosphonate salts, the mole ratio of the disodium to trisodium salt being from about 4:1 to 1:1, (iii) dichloromethane diphosphonic acid, or the pharmaceutically acceptable salts thereof, and (iv) methane diphosphonic acid, or the pharmaceutically acceptable salts thereof; B. an amount of an anhydrous reducing metal salt which is a member selected from the group consisting of stannous chloride and stannous sulfate sufficient to provide a molar ratio of stannous:phosphonate of from about 1:15 to 1:80.
Claim 3
Dependent Claim 34 words
A composition according to claim 1 wherein the phosphonate is a mixture of disodium- and trisodium-ethane-1-hydroxy-1,1-disphosphonate salts at a mole ratio of the disodium salt to the trisodium salt from about 3:1 to 1:1.
Claim 4
Dependent Claim 14 words
A composition according to claim 2 wherein the reducing metal salt is stannous chloride.
Claim 5
Dependent Claim 17 words
A composition according to claim 14 wherein the phosphonate is a sodium salt of dichloromethane diphosphonic acid.
Claim 6
Dependent Claim 16 words
The composition of claim 1 wherein the phosphonate is a sodium salt of methane diphosphonic acid.
Claim 7
Dependent Claim 16 words
The composition of claim 1 which additionally contains about 1 to 50 parts of sodium chloride.
Claim 8
Dependent Claim 68 words
A composition according to claim 1 consisting essentially of a dry mixture of: A. disodium- and trisodium-ethane-1-hydroxy-1,1-diphosphonate salts, at a mole ratio of the disodium salt to trisodium salt from about 3:1 to 1:1; B. an amount of stannous chloride sufficient to produce a mole ratio of stannous to phosphonate of from about 1:15 to 1:80; and c. from about 1 part to 50 parts of sodium chloride.

References Cited (Backward Citations)

US3471552A Cited
US3466361A Cited
US3787565A Cited
US3749556A Cited
US3735001A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-09-28 1980-03-29 1980-09-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-09-28 1984-03-29 1984-09-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-09-28 1988-03-29 1988-09-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag